human iPSC-derived cells from healthy and diseased patients (myocytes and skeletal myoblasts)
  • human iPSC-derived cells from healthy and diseased patients (myocytes and skeletal myoblasts)

myriamed offers high quality human iPSC-derived cells to be used in drug discovery and development. Our myrCell product pipeline includes:

myrCell-Cardio

Human iPSC-derived cardiomyocytes to be used for drugs screening and drug discovery.

iPSC-derived cardiomyocytes (cryopreserved)

myrCell-Skeletal

Human iPSC-derived cardiomyocytes to be used for drugs screening and drug discovery.

iPSC-derived skeletal myoblasts (cryopreserved)

myrCell-Stroma

iPSC-derived stroma cells (cryopreserved)

Each released batch of myrCells comes with a Certificate of Analysis. Please contact us for details.

Products

CONTACT US

About us

At myriamed we focus on heart and skeletal muscle. Our myrCell and myrTissue platforms define wanted and unwanted drug effects in a unique human context. myrScreen combines our expertise in phenotypic drug screens and enables deep phenotyping of drug effects on healthy or diseased human heart and skeletal muscle.

Favorites

Get in touch

myriamed GmbH
Rudolf-Wissell-Straße 28a
37079 Göttingen
Germany

+49 551 2887817 0

+49 551 2887817 1

Socials

Copyright 2021 Seaside Media. All Rights Reserved.
Privacy PolicyTerms of useLicense Agreement
Settings saved
Privacy settings

Select an option to continue

Allow necessary cookies and Google Fonts. This is required for the website to work properly

It will load necessary cookies, Google Fonts, Google Maps and Youtube

It will load necessary cookies, Google Fonts, Google Maps, Youtube and Google Analytics

Further information

The text, labels and radio buttons can be customized in the file mod_cookiebar.html5. Further information about which cookies are used in the theme Eclipse can be found here: Eclipse Manual - Cookies

Close
Search